The Switzerland-based pharma firm which focuses on the development of standard cancer care products, Helsinn, made an announcement today that Chief Operating Officer of the firm, Group General Manager, as well as, Giorgio Calderari have been appointed to the Board of Directors of the company. They gave joining on the 19th of June.
Giorgio Calderari has enormous experience in the managing of development of drug, global product launches, supply chain establishment, serving the role as Senior Management in chemical plants as Research and Development, and Chief Manufacturing Officer. At present, he is responsible for managing the operations of the Helsinn Group and is also part of the Board of Directors of a few partner firms, based in Ireland, China, Switzerland, and the United States.
He is the Chairperson of the Board of Farma Industria Ticino since 2009. Farma Industria Ticino is a Switzerland-based pharma firm which has around 31 partner firm based in Canton Ticino. In addition to this, he is also a Member of Board of various other renowned firms.
Announcement regarding the stepping down of Carlo Donati was also made today by Helsinn. Donati has served the company for 8 years as a member of Board.
The Chief Executive Officer, as well as the, Vice Chairman of Helsinn Group ‘Riccardo Braglia’ said that having getting to work with Giorgio for more than 30 years, I have witnessed how he has stood out because of his skill and hard work, inclusive of the long period at the Helsinn Advanced Synthesis in Biasca. He is the topmost when it comes to having the knowledge and a better understanding of the business. Mister Braglia said that they were very excited to have him on board with the company and he was sure that he will do efforts in his non-executive role on the Helsinn Board of Directors.